Normal or pathological? The imaginary invalid in no man’s land
DOI:
https://doi.org/10.3989/arbor.2013.763n5005Keywords:
Disease, Realism, Constructivism, Fiction, Disease mongering, Objectivity, Subjective realityAbstract
Is the boundary between the normal and the pathological real or fiction? Are health and disease just a matter of fact or are they value-laden? Here we present some examples of how alleged diseases can be invented and propagated by the industry (disease mongering) or by the methodology of medical science itself. We show that the boundary between health and disease is blurred and depends on individual and social representations, culture relative ways of categorising things and people, and by the society’s degree of medicalisation. However, we do not mean that it is not real, rather that it is more complex than expected, as the subjectivity of social constructions and individual experiences makes them no less real. Finally, we conclude that health and disease belong to both objective and subjective kinds of reality, so the fictional can be real.
Downloads
References
Angell, M. (2005). The Truth about the Drug Compagnies: how they deceive us and what to do about it. Is the Party Over? New York: Random House Trade Paperbacks.
Boorse, C. (1975). "On the distinction between disease and illness". Philosophy & Public Affairs, 5, 49-68.
Canguilhem, G. (1966). Le normal et le pathologique. Paris: PUF.
Cassels, A. & Moynihan, R. (2005). Selling Sickness. How Drug Companies Are Turning Us All Into Patients. Crows Nest: Allen & Unwin.
Coe, J. (2003). Healthcare: The lifestyle drugs outlook to 2008, unlocking new value in wellbeing. London: Reuters Business Insight.
Cosgrove, L.; Krimsky, S.; Vijayaraghavan, M. & Schneider, L. (2006). "Financial ties between DSM-IV panel members and the pharmaceutical industry". Psychotherapy and Psychosomatics, 75 (3), 154–160. http://dx.doi.org/10.1159/000091772 PMid:16636630
Delate, T.; Simmons, V. A. & Motheral, B. R. (2004). "Patterns of use of sildenafil among commercially insured adults in the United States": 1998-2002. Int J Impot Res, 16 (4), 313-318. http://dx.doi.org/10.1038/sj.ijir.3901191 PMid:14973524
Engelhardt, H. T. (1975). "The concepts of health and disease". En Evaluation and explanation in the biomedical sciences (pp. 125–141). Springer. Recuperado a partir de http://link.springer.com/chapter/10.1007/978-94-010-1769-5_9 http://dx.doi.org/10.1007/978-94-010-1769-5_9
Ereshefsky, M. (2009). "Defining 'health'and 'disease'". Studies in History and Philosophy of Science Part C, 40 (3), 221–227. http://dx.doi.org/10.1016/j.shpsc.2009.06.005 PMid:19720330
Forcades i Vila, T. (2006). Los crímenes de las grandes compa-ías farmacéuticas. Barcelona: Cristianisme i Justícia.
Foucault, M. (1961). Histoire de la folie à l'âge classique. Paris: Gallimard. PMid:13695832
Hacking, Ian. (2001). ¿La construcción social de qué? Barcelona: Paidós.
Hacking, Ian. (2004). "La fabrication des malades". La Recherche, (Hors-série 16), 46-48.
Hesslow, G. (1993). "Do we need a concept of disease?". Theoretical medicine, 14 (1), 1–14. http://dx.doi.org/10.1007/BF00993984
Hoffman, B. (2001). "Complexity of the Concept of Disease as Shown through Rival Theoretical Frameworks". Theoretical Medicine and Bioethics, 22, 211-236. http://dx.doi.org/10.1023/A:1011416302494
House of Commons Health Committee. (2005). The Influence of the Pharmaceutical Industry. London: House of Commons.
Illich, I. (1975). Némésis médicale : l'expropriation de la santé. (J.-P. Dupuy, Trad.). Paris: Seuil.
Laumann, E. O.; Paik, A. & Rosen, R. C. (1999). "Sexual dysfunction in the United States: Prevalence and predictors". JAMA: Journal of the American Medical Association, 281 (6):537-44. http://dx.doi.org/10.1001/jama.281.6.537 PMid:10022110
Lexchin, J. (2006). "Bigger and Better: How Pfizer Redefined Erectile Dysfunction". PLoS Medicine, 3 (4), e132. http://dx.doi.org/10.1371/journal.pmed.0030132 PMid:16597172 PMCid:PMC1434483
Moynihan, R. (2003). "The making of a disease: female sexual dysfunction". British Medical Journal, 326, 45-47. http://dx.doi.org/10.1136/bmj.326.7379.45 PMid:12511464 PMCid:PMC1124933
Moynihan, R. & Henry, D. (2006). "The Fight against Disease Mongering: Generating Knowledge for Action". PLoS Medicine, 3 (4), e191. http://dx.doi.org/10.1371/journal.pmed.0030191 PMid:16597180 PMCid:PMC1434508
Murphy, D. (2009, junio). "Concepts of Disease and Health". En E. N. Zalta (ed.), The Stanford Encyclopedia of Philosophy. Recuperado a partir de http://plato.stanford.edu/archives/sum2009/entries/health-disease/
Payer, L. (1992). Disease-Mongers: How Doctors, Drug Companies, and Insurers Are Making You Feel Sick. New York: Willey and Sons.
Pignarre, P. (2001). Comment la dépression est devenue une épidémie? Paris: La Découverte. Royal College of General Practitioners. (2004, agosto 17). RCGP warns against unhealthy pharmaceutical industry. Recuperado 13 de julio de 2011, a partir¡ de http://www.rcgp.org.uk/default.aspx?page=1609
Sen, A. (2002). "Health: perception versus observation". British Medical Journal, 324 (7342), 860. http://dx.doi.org/10.1136/bmj.324.7342.860
Tiefer, L. (2006). "Female Sexual Dysfunction: A Case Study of Disease Mongering and Activist Resistance". PLoS Medicine, 3 (4), e178. http://dx.doi.org/10.1371/journal.pmed.0030178 PMid:16597176 PMCid:PMC1434501
Wakefield, J. C. (1992). The concept of mental disorder: on the boundary between biological facts and social values. American Psychologist, 47 (3), 373. http://dx.doi.org/10.1037/0003-066X.47.3.373
Published
How to Cite
Issue
Section
License
Copyright (c) 2013 Consejo Superior de Investigaciones Científicas (CSIC)
This work is licensed under a Creative Commons Attribution 4.0 International License.
© CSIC. Manuscripts published in both the printed and online versions of this Journal are the property of Consejo Superior de Investigaciones Científicas, and quoting this source is a requirement for any partial or full reproduction.All contents of this electronic edition, except where otherwise noted, are distributed under a “Creative Commons Attribution 4.0 International” (CC BY 4.0) License. You may read here the basic information and the legal text of the license. The indication of the CC BY 4.0 License must be expressly stated in this way when necessary.
Self-archiving in repositories, personal webpages or similar, of any version other than the published by the Editor, is not allowed.
